2019 Q2 Form 10-Q Financial Statement
#000142757019000033 Filed on May 10, 2019
Income Statement
Concept | 2019 Q2 | 2019 Q1 | 2018 Q1 |
---|---|---|---|
Revenue | $386.0K | $1.800M | $1.346M |
YoY Change | -85.87% | 33.73% | -8.56% |
Cost Of Revenue | $679.0K | $1.232M | $769.0K |
YoY Change | -60.8% | 60.21% | -6.56% |
Gross Profit | -$293.0K | $543.0K | $577.0K |
YoY Change | -129.3% | -5.89% | -11.09% |
Gross Profit Margin | -75.91% | 30.17% | 42.87% |
Selling, General & Admin | $4.332M | $6.204M | $10.01M |
YoY Change | -40.25% | -38.0% | 68.45% |
% of Gross Profit | 1142.54% | 1734.14% | |
Research & Development | $1.788M | $2.439M | $2.639M |
YoY Change | -46.66% | -7.58% | 9.96% |
% of Gross Profit | 449.17% | 457.37% | |
Depreciation & Amortization | $430.0K | $433.0K | $100.0K |
YoY Change | -69.06% | 333.0% | 233.33% |
% of Gross Profit | 79.74% | 17.33% | |
Operating Expenses | $6.120M | $8.643M | $12.65M |
YoY Change | -42.28% | -31.65% | 51.62% |
Operating Profit | -$6.413M | -$8.100M | -$12.07M |
YoY Change | -33.21% | -32.88% | 56.91% |
Interest Expense | -$295.0K | -$190.0K | -$37.00K |
YoY Change | 417.54% | 413.51% | -31.48% |
% of Operating Profit | |||
Other Income/Expense, Net | -$59.00K | $0.00 | -$21.00K |
YoY Change | -37.23% | -100.0% | |
Pretax Income | -$16.51M | -$4.476M | -$8.760M |
YoY Change | -19.56% | -48.9% | 18.86% |
Income Tax | -$586.0K | $0.00 | -$1.380M |
% Of Pretax Income | |||
Net Earnings | -$6.767M | -$8.290M | -$12.13M |
YoY Change | -30.62% | -31.63% | 56.57% |
Net Earnings / Revenue | -1753.11% | -460.56% | -900.89% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$150.2M | -$65.16M | -$59.98B |
COMMON SHARES | |||
Basic Shares Outstanding | 24.00M shares | 23.50M shares | 17.61M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2019 Q2 | 2019 Q1 | 2018 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $4.355M | $1.828M | $840.0K |
YoY Change | 134.14% | 117.62% | -95.5% |
Cash & Equivalents | $13.51M | $24.68M | $33.48M |
Short-Term Investments | $0.00 | $0.00 | $0.00 |
Other Short-Term Assets | $954.0K | $1.539M | $1.187M |
YoY Change | 11.32% | 29.65% | 18.23% |
Inventory | $2.107M | $1.860M | $1.867M |
Prepaid Expenses | $954.0K | $1.539M | $1.006M |
Receivables | $447.0K | $1.829M | $2.553M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $17.02M | $29.91M | $39.09M |
YoY Change | -45.02% | -23.47% | -43.91% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $1.038M | $1.222M | $1.422M |
YoY Change | -31.44% | -14.06% | 57.48% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $563.0K | $563.0K | $230.0K |
YoY Change | 603.75% | 144.78% | -66.18% |
Total Long-Term Assets | $2.178M | $2.456M | $1.422M |
YoY Change | 43.86% | 72.71% | 57.48% |
TOTAL ASSETS | |||
Total Short-Term Assets | $17.02M | $29.91M | $39.09M |
Total Long-Term Assets | $2.178M | $2.456M | $1.422M |
Total Assets | $19.20M | $32.37M | $40.51M |
YoY Change | -40.87% | -20.09% | -42.62% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.082M | $1.044M | $2.304M |
YoY Change | -25.12% | -54.69% | 334.72% |
Accrued Expenses | $343.0K | $374.0K | $5.870M |
YoY Change | -92.38% | -93.63% | 84.59% |
Deferred Revenue | $320.0K | $370.0K | |
YoY Change | 5.96% | ||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $5.000M | $19.95M | $2.961M |
YoY Change | 26.1% | 573.83% | |
Total Short-Term Liabilities | $10.09M | $25.03M | $9.110M |
YoY Change | -2.94% | 174.76% | 150.9% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $6.973M |
YoY Change | -100.0% | -100.0% | -29.5% |
Other Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Total Long-Term Liabilities | $722.0K | $819.0K | $6.973M |
YoY Change | -88.01% | -88.25% | -29.5% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $10.09M | $25.03M | $9.110M |
Total Long-Term Liabilities | $722.0K | $819.0K | $6.973M |
Total Liabilities | $10.81M | $25.85M | $16.08M |
YoY Change | -34.15% | 60.73% | 18.94% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$163.8M | -$157.0M | -$123.5M |
YoY Change | 22.88% | 27.13% | 46.41% |
Common Stock | $172.2M | $163.6M | $147.9M |
YoY Change | 15.33% | 10.57% | 4.58% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $8.376M | $6.518M | $24.42M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $19.20M | $32.37M | $40.51M |
YoY Change | -40.87% | -20.09% | -42.62% |
Cashflow Statement
Concept | 2019 Q2 | 2019 Q1 | 2018 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$6.767M | -$8.290M | -$12.13M |
YoY Change | -30.62% | -31.63% | 56.57% |
Depreciation, Depletion And Amortization | $430.0K | $433.0K | $100.0K |
YoY Change | -69.06% | 333.0% | 233.33% |
Cash From Operating Activities | -$2.900M | -$9.642M | -$10.60M |
YoY Change | -55.38% | -9.05% | 26.92% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $19.00K | $358.0K |
YoY Change | -100.0% | -94.69% | -6.04% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
Cash From Investing Activities | $0.00 | $2.531M | $22.94M |
YoY Change | -100.0% | -88.97% | -200.15% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $607.0K | $0.00 | |
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 5.427M | $10.61M | $28.00K |
YoY Change | -27.93% | 37785.71% | |
NET CHANGE | |||
Cash From Operating Activities | -2.900M | -$9.642M | -$10.60M |
Cash From Investing Activities | 0.000 | $2.531M | $22.94M |
Cash From Financing Activities | 5.427M | $10.61M | $28.00K |
Net Change In Cash | 2.527M | $3.497M | $12.37M |
YoY Change | 147.75% | -71.73% | -139.57% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$2.900M | -$9.642M | -$10.60M |
Capital Expenditures | $0.00 | $19.00K | $358.0K |
Free Cash Flow | -$2.900M | -$9.661M | -$10.96M |
YoY Change | -55.32% | -11.85% | 25.49% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2019Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2019Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2019Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2019Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2019 | |
CY2019Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2019-03-31 | |
CY2019Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2019Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001427570 | |
CY2019Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
24000751 | shares |
CY2019Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2019Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
true | |
CY2019Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2019Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
OBALON THERAPEUTICS INC | |
CY2019Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2019Q1 | dei |
Trading Symbol
TradingSymbol
|
OBLN | |
CY2018Q4 | obln |
Accrued Customer Incentives Current
AccruedCustomerIncentivesCurrent
|
467000 | USD |
CY2019Q1 | obln |
Accrued Customer Incentives Current
AccruedCustomerIncentivesCurrent
|
485000 | USD |
CY2018Q4 | obln |
Accrued Legal And Professional Fees Current
AccruedLegalAndProfessionalFeesCurrent
|
624000 | USD |
CY2019Q1 | obln |
Lease Right Of Use Asset
LeaseRightOfUseAsset
|
1234000 | USD |
CY2019Q1 | obln |
Accrued Legal And Professional Fees Current
AccruedLegalAndProfessionalFeesCurrent
|
542000 | USD |
CY2019Q1 | obln |
Cash And Cash Equivalents Available For Use
CashAndCashEquivalentsAvailableForUse
|
4700000 | USD |
CY2019Q1 | obln |
Operating Lease Rightof Use Asset Amortization
OperatingLeaseRightofUseAssetAmortization
|
92000 | USD |
CY2019Q1 | obln |
Cash Minimum Before Possible Default
CashMinimumBeforePossibleDefault
|
20000000 | USD |
CY2019Q1 | obln |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
-42000 | USD |
CY2019Q1 | obln |
Lease Liability Current
LeaseLiabilityCurrent
|
465000 | USD |
CY2019Q1 | obln |
Lease Liability Noncurrent
LeaseLiabilityNoncurrent
|
819000 | USD |
CY2018Q4 | us-gaap |
Assets
Assets
|
30386000 | USD |
CY2019Q1 | obln |
Sharebased Compensation Arrangementby Sharebased Payment Award Non Option Equity Instruments Vestedand Expectedto Vest Outstanding Aggregate Intrinsic Value
SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsVestedandExpectedtoVestOutstandingAggregateIntrinsicValue
|
114000 | USD |
CY2019Q1 | obln |
Sharebased Compensation Arrangementby Sharebased Payment Award Non Option Equity Instruments Vestedand Expectedto Vest Outstanding Number
SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsVestedandExpectedtoVestOutstandingNumber
|
79174 | shares |
CY2019Q1 | obln |
Sharebased Compensation Arrangementby Sharebased Payment Award Non Option Equity Instruments Vestedand Expectedto Vest Outstanding Weighted Average Exercise Price
SharebasedCompensationArrangementbySharebasedPaymentAwardNonOptionEquityInstrumentsVestedandExpectedtoVestOutstandingWeightedAverageExercisePrice
|
2.30 | |
CY2018Q1 | obln |
Unpaid Stock Issuance Costs
UnpaidStockIssuanceCosts
|
0 | USD |
CY2019Q1 | obln |
Unpaid Stock Issuance Costs
UnpaidStockIssuanceCosts
|
26000 | USD |
CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1159000 | USD |
CY2019Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1044000 | USD |
CY2018Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
870000 | USD |
CY2019Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1829000 | USD |
CY2018Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
5000 | USD |
CY2019Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
2000 | USD |
CY2018Q4 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
0 | USD |
CY2019Q1 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
241000 | USD |
CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1979000 | USD |
CY2019Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2124000 | USD |
CY2018Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
161838000 | USD |
CY2019Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
163538000 | USD |
CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
14000 | USD |
CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
14000 | USD |
CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1389000 | USD |
CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1105000 | USD |
CY2018Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
239000 | USD |
CY2019Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
861000 | USD |
CY2018Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
11000 | USD |
CY2019Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
22000 | USD |
CY2018Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
596209 | shares |
CY2019Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
182184 | shares |
CY2019Q1 | us-gaap |
Assets
Assets
|
32368000 | USD |
CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
28647000 | USD |
CY2019Q1 | us-gaap |
Assets Current
AssetsCurrent
|
29912000 | USD |
CY2018Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
46000 | USD |
CY2019Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
4000 | USD |
CY2019Q1 | us-gaap |
Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
|
P1Y | |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
21187000 | USD |
CY2019Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
24684000 | USD |
CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
21108000 | USD |
CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
33478000 | USD |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
21187000 | USD |
CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
24684000 | USD |
CY2018Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
12370000 | USD |
CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
3497000 | USD |
CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2019Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2019Q1 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
6203431 | shares |
CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2019Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2019Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
23513292 | shares |
CY2019Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
24249478 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
23513292 | shares |
CY2019Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
24249478 | shares |
CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
23000 | USD |
CY2019Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
24000 | USD |
CY2018Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-12120000 | USD |
CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-8290000 | USD |
CY2018Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
352000 | USD |
CY2019Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
370000 | USD |
CY2018Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
769000 | USD |
CY2019Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1232000 | USD |
CY2019Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
20000000 | USD |
CY2019Q1 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
48000 | USD |
CY2018Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
100000 | USD |
CY2018Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
129000 | USD |
CY2019Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
200000 | USD |
CY2019Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
150000 | USD |
CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.71 | |
CY2019Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.36 | |
CY2018Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3805000 | USD |
CY2019Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
986000 | USD |
CY2019Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
5700000 | USD |
CY2019Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y1M1D | |
CY2018Q1 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-107000 | USD |
CY2019Q1 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
0 | USD |
CY2018Q1 | us-gaap |
Gross Profit
GrossProfit
|
577000 | USD |
CY2019Q1 | us-gaap |
Gross Profit
GrossProfit
|
543000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1074000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-137000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1670000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
959000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-173000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
18000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-2663000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-2819000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
449000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-102000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-527000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-923000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-93000 | USD |
CY2019Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
195000 | USD |
CY2018Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-37000 | USD |
CY2019Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-190000 | USD |
CY2018Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
149000 | USD |
CY2019Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
205000 | USD |
CY2018Q4 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
12000 | USD |
CY2019Q1 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
0 | USD |
CY2018Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
202000 | USD |
CY2019Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
198000 | USD |
CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
1580000 | USD |
CY2019Q1 | us-gaap |
Inventory Net
InventoryNet
|
1860000 | USD |
CY2018Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
1090000 | USD |
CY2019Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
1595000 | USD |
CY2018Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
288000 | USD |
CY2019Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
67000 | USD |
CY2018Q1 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
100000 | USD |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1429000 | USD |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
116000 | USD |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
489000 | USD |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
475000 | USD |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
349000 | USD |
CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
145000 | USD |
CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
17279000 | USD |
CY2019Q1 | us-gaap |
Liabilities
Liabilities
|
25850000 | USD |
CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
30386000 | USD |
CY2019Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
32368000 | USD |
CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
17231000 | USD |
CY2019Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
25031000 | USD |
CY2018Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
48000 | USD |
CY2019Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
819000 | USD |
CY2019Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
19952000 | USD |
CY2018Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
9930000 | USD |
CY2019Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
19952000 | USD |
CY2019Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
0 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
28000 | USD |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
10608000 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
22944000 | USD |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
2531000 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10602000 | USD |
CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9642000 | USD |
CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12126000 | USD |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8290000 | USD |
CY2019Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment |
CY2018Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
12645000 | USD |
CY2019Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
8643000 | USD |
CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
19000 | USD |
CY2018Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
2329000 | USD |
CY2019Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
1539000 | USD |
CY2018Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
CY2019Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
607000 | USD |
CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12068000 | USD |
CY2019Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8100000 | USD |
CY2019Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
100000 | USD |
CY2019Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1284000 | USD |
CY2019Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
465000 | USD |
CY2019Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
819000 | USD |
CY2019Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
100000 | USD |
CY2019Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.070 | |
CY2019Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y | |
CY2018Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
762000 | USD |
CY2019Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
807000 | USD |
CY2018Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
2462000 | USD |
CY2019Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
1539000 | USD |
CY2018Q4 | us-gaap |
Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
|
121000 | USD |
CY2019Q1 | us-gaap |
Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
|
0 | USD |
CY2018Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
6000 | USD |
CY2019Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
0 | USD |
CY2018Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
1985000 | USD |
CY2019Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
2214000 | USD |
CY2018Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
48000 | USD |
CY2019Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
0 | USD |
CY2018Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-21000 | USD |
CY2019Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | USD |
CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
358000 | USD |
CY2018Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | USD |
CY2019Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
10000000 | USD |
CY2018Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
23302000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
2550000 | USD |
CY2018Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
28000 | USD |
CY2019Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1000 | USD |
CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3718000 | USD |
CY2019Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3346000 | USD |
CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1739000 | USD |
CY2019Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1222000 | USD |
CY2019Q1 | us-gaap |
Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
|
1500000 | USD |
CY2018Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2639000 | USD |
CY2019Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2439000 | USD |
CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-148754000 | USD |
CY2019Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-157044000 | USD |
CY2019Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-157000000 | USD |
CY2018Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1346000 | USD |
CY2018Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1300000 | USD |
CY2019Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1775000 | USD |
CY2019Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1800000 | USD |
CY2019Q1 | us-gaap |
Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
|
three to six months | |
CY2018Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
132000 | USD |
CY2019Q1 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
139000 | USD |
CY2018Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
10006000 | USD |
CY2019Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6204000 | USD |
CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1389000 | USD |
CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1105000 | USD |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
16952 | shares |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
819615 | shares |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
209000 | USD |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3360048 | shares |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4161530 | shares |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
5.83 | |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
5.14 | |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
206000 | USD |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
1807538 | shares |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
6.02 | |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
209000 | USD |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
3868235 | shares |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
5.20 | |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.87 | |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
5.14 | |
CY2019Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
2.28 | |
CY2019Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y6M8D | |
CY2019Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P6Y7M12D | |
CY2019Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P7Y6M6D | |
CY2018Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
2548000 | USD |
CY2019Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
0 | USD |
CY2019Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
1181 | shares |
CY2019Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
581000 | USD |
CY2018Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
28000 | USD |
CY2019Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1000 | USD |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13107000 | USD |
CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6518000 | USD |
CY2017Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
35113000 | USD |
CY2018Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
24424000 | USD |
CY2018Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
13107000 | USD |
CY2019Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
6518000 | USD |
CY2018Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
16986656 | shares |
CY2019Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
23112582 | shares |
CY2019Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Credit Risk </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash equivalents and trade accounts receivable, which are generally not collateralized. The Company limits its exposure to credit loss by placing its cash equivalents with high credit quality financial institutions and investing in high quality short-term debt instruments. The Company’s customers consist of physicians and institutions in the United States and one international distributor. The Company establishes customer credit policies related to its accounts receivable based on historical collection experiences within the various markets in which the Company operates, historical past-due amounts, and any specific information that the Company becomes aware of such as bankruptcy or liquidity issues of customers. </font></div></div> | |
CY2019Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reported amounts and note disclosures reflect the overall economic conditions that are most likely to occur and anticipated measures management intends to take. Actual results could differ materially from those estimates. All revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.</font></div></div> |